** Healthcare company OPKO HealthOPKShares rose 2.8% to $1.10 pre-market

**Clinical Laboratory Operator LabcorpLHWill acquire certain assets of BioReference Health, a subsidiary of OPKO Health, for US$237.5 million (link)

**The assets to be acquired by LH currently have annual revenues of approximately $100 million

** Through this transaction, LH will acquire BioReference's laboratory testing operations across the United States (excluding New York and New Jersey), with a focus on clinical diagnostics and women's health.

** BioReference will continue to provide oncology and urology diagnostic services nationwide and maintain full operations in New York and New Jersey, the companies said

** Transaction expected to close in second half of 2024

** As of the last close, OPK had fallen 29.1% year-on-year.